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Vector-borne diseases result from infections
transmitted to humans and other animals by
blood-feeding arthropods, such as mosqui-
toes, ticks, and fleas. The vector-borne
pathogens, which include viruses, rickettsiae,
bacteria, protozoa, and worm parasites, spend
part of their life cycle in a cold-blooded
arthropod vector and thus are influenced by
environmental change. The transmission pat-
terns of these diseases may, therefore, be
affected by ambient temperature. However,
temperature is only one of many factors that
inﬂuence transmission dynamics (Figure 1).
Rodent-borne diseases do not always
involve an arthropod host and are therefore
less directly affected by temperature.
Transmission of these infections frequently
depends on rodent population density and
behavior, which, in turn, depend upon
environmental conditions and available food.
Many vector-borne diseases are zoonoses
caused by pathogens having nonhuman ani-
mals as their natural host. Because they are
not part of the natural transmission cycle,
humans are only incidentally infected.
Zoonoses usually persist in nature in silent
transmission cycles between vectors and non-
human hosts, going undetected unless they
spill over and infect the human population.
In contrast, the anthropogenic vector-borne
diseases, such as dengue fever and malaria,
require no animal host and are transmitted
from human to human by mosquito vectors.
Although these disease-causing pathogens are
now rare in the United States, their mosquito
vectors are still present. 
Mosquito-Borne Diseases
Mosquito-borne diseases were once a major
public health problem in the United States.
From the 1600s to the mid-1900s, malaria was
endemic (with occasional large epidemics)
throughout much of the country and into
Eastern Canada. Epidemics of dengue and yel-
low fever occurred regularly during the summer
months, as far north as Boston, Massachusetts,
and Philadelphia, Pennsylvania. In the 1900s,
other mosquito-borne diseases, such as St.
Louis encephalitis (SLE) and western equine
encephalitis (WEE), appeared in epidemic
form. Dengue, yellow fever, and malaria had
disappeared by the middle of the twentieth cen-
tury, although their mosquito vectors were and
still are present. Moreover, the incidence of
indigenous diseases, such as SLE and WEE, has
decreased because of changing agricultural
practices, improved housing and sanitation
and, in some areas, effective mosquito control.
Dengue. Among vector-borne diseases,
dengue is second only to malaria in the num-
ber of people affected worldwide. A global
pandemic of dengue fever, a mosquito-borne
viral disease, began during World War II,
intensifying since the 1970s (1). Today, popu-
lation growth, urbanization, and increased
movement of people, viruses, and mosquitoes
contribute to continued geographic spread and
increased incidence of the disease. Although
dengue is not endemic in the continental
United States, it is endemic in the U.S.
Commonwealth of Puerto Rico. In addition,
more than 2,706 suspected and 584 conﬁrmed
cases of dengue in U.S. residents who had trav-
eled abroad were reported from 1977 to 1995
(1–3), but this is considered to be underre-
ported (4–6). There have been six reported
instances of local transmission (1980, 27 cases;
1986, 9 cases; 1995, 7 cases; 1997, 3 cases;
1998, 1 case; 1999, 17 cases) in Texas over the
last 20 years, with most linked to imported
cases from Mexico (3,5,6).
Concerns that dengue may be introduced
to the United States from neighboring coun-
tries have heightened disease surveillance and
interventions in border cities of Texas.
Comparison of dengue incidence between the
United States and Mexico showed that
62,514 dengue cases were reported in the
three Mexican states adjoining Texas between
1980 and 1999 (7), whereas only 64 locally
acquired cases were reported in Texas
between 1980 and 1997 (7). The large differ-
ence in disease incidence between U.S. and
Mexico border states is probably caused by
differences in living standards and human
behavior, although this has not been exten-
sively investigated. Factors such as piped
water systems, door and window screens, air
conditioning, television, and human behavior
undoubtedly decrease the probability of the
mosquito’s feeding on humans in the United
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States and decrease the probability of dengue
transmission.
Despite eradication efforts during the
1950s and 1960s, Aedes aegypti, the principal
and most efficient epidemic vector of urban
dengue, has been common throughout the
Southeastern United States for over 220 years.
In recent years, however, this species has been
displaced in many states by another mosquito
species, Aedes albopictus, ﬁrst detected in 1985
in Texas (8–10). This species is now a perma-
nent resident of many states in the eastern half
of the United States. Although not an impor-
tant epidemic vector of dengue, it probably is
involved in the maintenance cycle of dengue
in rural and suburban areas of Asia (11). 
In Puerto Rico, dengue transmission
occurs year round, with a seasonal peak dur-
ing months with high rainfall and humidity
(usually September–November). Large epi-
demics occurred in 1963, 1969, 1977, 1978,
1982, 1986, and 1994 despite relatively high
living standards, an efficient health system,
and active disease surveillance (12). The fac-
tors that determine whether epidemic trans-
mission will occur are complex and not well
understood, but involve the interaction of
host-, virus-, and vector-associated factors.
One factor important in causing epidemics
and increasing the severity of disease is the
introduction of new dengue viruses to the
island by travelers, causing the cocirculation
of multiple virus serotypes (hyperendemicity)
(13). Expanding urban populations in the
tropics also permit conditions for endemic
transmission and potential cocirculation of
multiple serotypes. Approximately 355,000
cases of dengue fever were reported during
the 1977 outbreak, at an estimated cost of
$10.3 million (14). Data from 1984 to 1994
indicated an average of 658 disability-
adjusted life-years lost from dengue per mil-
lion people in Puerto Rico per year, a loss on
par with other high-priority infectious dis-
eases such as tuberculosis and malaria (15). A
recent study by Gubler and Meltzer (16)
showed a similar economic impact on a
global scale.
Yellow fever. Yellow fever is a mosquito-
borne viral disease maintained in a forest
cycle involving lower primates and canopy-
dwelling mosquitoes in tropical Africa and
America. Epidemics occur when the virus is
introduced into suburban and urban environ-
ments where the Ae. aegypti mosquito serves
as the primary vector among humans (17).
The reinfestation of many South American
tropical cities by Ae. aegypti (18), combined
with low vaccination rates against yellow
fever, provides the potential for explosive
urban outbreaks (18,19). If that occurs, the
virus has the potential to spread to Asia and
the Paciﬁc, and the United States and Europe
could expect a dramatic increase in imported
yellow fever cases for the same reasons
observed with dengue fever (20,21). In the
United States, epidemic yellow fever was
eliminated through quarantine and mosquito
control in some areas and by improved living
standards. Although the urban infrastructure
in North America today is less conducive to
mosquito transmission than that in South
America, much of the Southeastern United
States is still infested with Ae. aegypti.
However, it is being displaced rapidly by Ae.
albopictus, a less efficient vector. There
remains a remote possibility that yellow fever
could recur in the United States (19,22–24).
Viral encephalitis. Arboviral encephalitides
are infections of the central nervous system
caused by mosquito-borne viruses. Unlike
dengue and yellow fever, these infections are
currently enzootic (i.e., indigenous in ani-
mal hosts) in a wide range of ecologic envi-
ronments within the continental United
States. The natural transmission cycles
involve birds and rodents as reservoirs of the
viruses (25). Human beings are incidental
hosts and do not produce sufficient viremia
to infect mosquitoes (26). 
In the summer of 1999, West Nile virus
(WNV) was imported into the United States
and caused an outbreak of encephalitis in
New York; 62 laboratory-positive cases,
including seven deaths, were documented
(27). In 1996, a major WNV epidemic
occurred in Romania with a high rate of
neurologic infections (28,29). These out-
breaks illustrate the need for improved sur-
veillance and risk assessment for unexpected
introductions of infectious agents potentially
brought in by imported animals or humans as
international trade and travel increases.
The arboviral disease most commonly
causing human epidemics in the United
States is SLE. Other common diseases
include eastern equine encephalomyelitis
(EEE), found in the Eastern United States; La
Crosse encephalitis (LAC), found from the
Midwest to the Atlantic seaboard; and WEE,
found in the western half of the United States
and parts of Canada and Mexico. Together,
these viruses account for about 65% of
encephalitis cases reported by etiology (30). 
No effective vaccine or antiviral treatment
is available for SLE, and the elderly are dispro-
portionately affected (31). Major epidemics of
SLE have occurred in large cities of the
Midwestern and Eastern United States, such
as Houston and Dallas, Texas; Chicago,
Illinois; Memphis, Tennessee; and Orlando,
Florida. The largest was in 1975, when 1,270
laboratory positive cases and 102 deaths were
reported in 10 outbreaks in the Midwest (32).
However, over the past 30 years, a median of
26 SLE cases have been reported each year in
the United States (33), with most recent
activity concentrated in Florida (34). 
Widespread immunization against WEE
prevents equine disease, and human cases are
extremely rare. LAC virus is associated with
tree hole-breeding mosquitoes and rodents in
wood lots, and an average of 75 LAC cases
are reported each year. EEE is transmitted
among wild birds in swamp habitat by a mos-
quito (Culiseta melanura) that does not nor-
mally bite humans (35). Although outbreaks
are small and human EEE cases are relatively
Figure 1. Potential vector- and rodent-borne diseases. aModerating inﬂuences include nonclimate factors that affect
climate-related health outcomes, such as standards of living, access to health care, international travel, and public
health infrastructure. bAdaptation measures include actions to reduce risks of adverse health outcomes, such as med-
ical technology (e.g., vaccine development) or use of climate forecasts for early warning of favorable conditions for
disease transmission.
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rare (about five cases per year), case fatality
rates approximate 30%, with neurologic
sequelae common among survivors. The
number of cases is low but the economic
impact per case has been estimated at about
$3,000,000 (36).
In recent years, the number of human
cases of arboviral encephalitis has been
decreasing, but that may change with the
introduction of WNV. It is likely that all of
these viruses will persist within their natural
enzootic cycles and continue to pose a health
risk to the human population whenever eco-
logic conditions or failed control programs
allow increased ampliﬁcation.
Invasion of imported arboviral mosquito
vectors. Imported mosquito species also must
be considered. Ae. albopictus, the Asian tiger
mosquito, was ﬁrst found in Houston, Texas,
in 1985 (37). Within a few years it spread to
25 states in the South, mid-Atlantic, and
Midwest (38–40), often displacing native Ae.
aegypti (40,41). It should be noted that the
introduction of Ae. albopictus into the United
States had nothing to do with climate change
(42); this species is similar genetically to tem-
perate strains in Asia (43). Ae. albopictus
rarely has been implicated in epidemic
dengue and dengue hemorrhagic fever trans-
mission in the Paciﬁc and Asia, and its catholic
feeding habits and less frequent contact with
humans indicate that it may not increase the
risk of dengue transmission in the West (11).
Its potential importance in the United States is
that it is an aggressive diurnal biter and could
serve as a bridge vector for viruses such as
LAC, EEE, and others, thus potentially
increasing human risk to infection (40). Under
experimental conditions, Ae. albopictus is a
competent vector for 22 arboviruses (40),
including all four dengue serotypes (44), yel-
low fever (45), Chikungunya (46), and Ross
River virus (47). Although there is still no
direct evidence that Ae. albopictus transmits
human disease in the United States (40), eight
arboviruses—Cache Valley, Potosi, Tensaw,
EEE, Keystone, Jamestown Canyon, LAC,
and WNV—have been isolated from this
species (40,48). In 1997, the mosquito was
detected in Peoria, Illinois, an area with long-
term LAC transmission (49). Surveillance in
Peoria showed that Ae. albopictus competed
well against the resident mosquito species,
Aedes triseriatus, but there was no evidence
that Ae. albopictus transmitted LAC virus to
humans (49).
Malaria. Malaria is currently the world’s
most widespread and serious vector-borne
disease. Although malaria was once controlled
effectively in many parts of the world, disease
incidence has increased greatly over the past
two decades because of a variety of demo-
graphic, political, societal, and public health
changes (22,50). The United States has
competent malaria vectors, with each area of
the country having its own species of
Anopheles mosquitoes. Anopheles quadrimac-
ulatus, for example, occurs in the east, and
Anopheles hermsi and Anopheles freeborni
occur in southern California. Many anophe-
line species can transmit malaria, including
the two most common species of malaria
parasite,  Plasmodium falciparum and
Plasmodium vivax (51).
The initial decline in malaria in the
United States was attributed to a population
shift from rural to urban areas, improved
water management, improved housing and
nutrition, better standards of living, and
greater access to medical services (42). Vector
control and improved case ﬁnding and treat-
ment were important in eliminating malaria
from the Continental United States by 1950. 
Since 1957, nearly all malaria diagnosed
in the United States has been imported.
About 1,200 cases of malaria are reported
annually, making it the most common
imported vector-borne disease, and many
cases likely go unreported. There are reports
of malaria acquired through local mosquito
transmission in nearly all parts of the United
States, and this number may be increasing
because of increased immigration/travel.
Most cases occur in rural areas among
migrant farm workers (22). Although such
locally acquired malaria cases result in only a
few cases per outbreak, many U.S. areas are at
risk for limited local transmission. Recent
small outbreaks in urban or suburban areas
have occurred in New Jersey (1991), New
York (1993 and 1999), Texas (1993),
Michigan (1995), and Georgia (1999) (52).
Tick-Borne Diseases 
Lyme disease. Lyme disease was ﬁrst discovered
in the United States in 1975. Since surveil-
lance began in 1982, the number of reported
cases per year has increased from 497 to
15,934 cases in 1998, making it the most
common vector-borne disease in the United
States today. Lyme disease, caused by infec-
tion with the spirochete Borrelia burgdorferi,
is transmitted to humans in the upper
Midwest and Northeast by the hard tick
Ixodes scapularis and in the West by Ixodes
pacificus. Transmission is seasonal, with the
peaks in June and July associated with the
questing period of the nymphal stages of the
tick. Cases have been reported in all states
and the District of Columbia, with over 90%
occurring in 10 states: in the Northeast
(Connecticut, Maryland, Massachusetts, New
Jersey, New York, Pennsylvania, Rhode
Island), Upper Midwest (Minnesota,
Wisconsin), and California (50,53).
The rapid emergence of Lyme disease is
linked to changes in land use patterns (22),
such as farmland reforestation and residential
development within wooded areas.
New-growth forests with extensive edge
(between forest and open land) led to an
explosion in deer populations, which are the
primary hosts for adult ticks. The close prox-
imity of people, tick vectors, white-footed
mice (the reservoir host for the bacteria), and
deer in suburban settings has enhanced disease
transmission (22). Improved surveillance, case
definition, clinical and laboratory diagnosis,
and reporting have increased the number and
accuracy of the cases detected. 
Other tick-borne diseases. Rocky Mountain
spotted fever (RMSF) is a bacterial disease
caused by Rickettsia rickettsii that is distributed
throughout much of the United States, parts
of Canada, and Central and South America.
RMSF is transmitted by several species of
Ixodid (hard) ticks. Natural reservoirs include
rodents and other mammals, including dogs. 
In recent years, about 800 cases were
reported annually in the United States, of
which 3–5% were fatal. If left untreated, case
fatality rates can be as high as 13–25%, espe-
cially in the very young and elderly (54).
Most RMSF cases occur in the eastern
United States (New York to Florida) and in
the South (Alabama to Texas) and are most
common between April and September,
although transmission can occur during warm
winters (55). The transmission season is
longer in warmer regions.
Human ehrlichiosis, ﬁrst recognized in the
United States in 1986, is a tick-borne disease
caused by several species of bacteria of the
subfamily Rickettsiaceae. Since 1986, more
than 500 cases have been reported to the
Centers for Disease Control and Prevention
(CDC). Infection can be severe and is occa-
sionally fatal. Like Lyme disease, ehrlichiosis is
maintained enzootically by Ixodid tick trans-
mission among animal reservoirs (56), such as
white-tailed deer and rodents, and is found in
mild climatic conditions (e.g., southern lati-
tude, low elevation) (57). 
Most ehrlichiosis cases are reported in the
Southeastern United States and South-
Central States during spring and summer,
though cases have also been reported in the
Northeast and Midwest (58). Since 1986,
rodents from 14 states were found to have
been infected with erhlichia (59). Rodent
samples collected between 1984 and 1988 in
Baltimore, Maryland, suggest that ehrlichiosis
was present in mice at least 12 years before
human cases were first recognized (60). The
two main ehrlichia that cause disease in the
United States and animal cycles of the bacte-
ria are likely to exist in areas where human
disease is not yet conﬁrmed (59).
The Ixodes tick is also the carrier of
Babesia microti, the infectious protozoan
agent that causes babesiosis. Most cases in the
United States have occurred in the Northeast
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(61). Coinfection of babesiosis also occurs
with Lyme disease and ehrlichiosis.
Tularemia is an acute bacterial disease
transmitted to humans by hard ticks, biting
flies, and direct contact with infected wild
animals such as rabbits, hares, muskrats,
and beavers. The disease is most prevalent
during June–August, particularly following
floods. Clinical manifestations are varied,
but fatality rates among untreated patients
may be as high as 60%. In the United
States, reported cases decreased from about
1,400 per year in the 1950s to around 100
per year today. Cases occur primarily in the
Northeastern, Southeastern, and Western
United States (62).
Colorado tick fever is a viral zoonosis of
small mammals, endemic to mountainous
regions above 5,000 feet in the Western
United States and Canada. The disease is
usually associated with recreational exposure,
e.g., among hikers and hunters (63). Tick-
borne relapsing fever is caused by a spiro-
chete found naturally in several rodent
species and transmitted to humans by soft
ticks. The disease occurs primarily in moun-
tainous areas of the western United States,
and human infection is usually associated
with exposure in mountain cabins that are
not rodent proof.
Flea-Borne Diseases
Plague. Plague is a bacterial disease trans-
mitted by the bite of infected ﬂeas, by direct
contact with infected animals, and by inhal-
ing infective bacteria. Although only 200
cases were reported worldwide in 1981,
there has been a resurgence of epidemic
plague, focally in all major regions of the
world and particularly in Africa, where
about 3,000 cases are now reported annu-
ally. In the United States, plague circulates
enzootically among wild rodents from the
paciﬁc coast to the western edge of the Great
Plains, with incidental transmission to
humans. The last urban plague epidemic in
the United States occurred in 1924; at pre-
sent, an average of 14 human cases occur in
the United States per year (64), with a
2-fold higher incidence in adult males than
females (65). The largest numbers of cases
occur in New Mexico, Arizona, California,
and Colorado (64). 
Rodent-Borne Diseases 
Hantavirus pulmonary syndrome. There are
at least 30 different hantaviruses worldwide
(genus Bunyavirus), many of which can cause
severe, often fatal, illness in humans (66).
These viruses are carried by numerous rodent
species and transmitted to humans through
rodent urine, droppings, and saliva. In 1993,
a previously unknown hantavirus, Sin
Nombre, emerged in the Four Corners
region of the rural Southwestern United
States, causing an acute respiratory disease
named hantavirus pulmonary syndrome
(67). As of 1997, over 164 cases were con-
ﬁrmed in the United States and over 400 in
the Americas, with a fatality rate of 45% in
otherwise healthy individuals (68). The
severity and wide geographic distribution of
this rodent-borne disease prompted intensive
collaborations between public health investi-
gators and ecologists to determine the factors
leading to infection in host rodents and
humans (66,69). Cases most frequently have
been associated with indoor exposure after
infected field rodents invade buildings,
usually during harsh ecologic conditions
following favorable weather periods. 
The development of a human vaccine has
been proposed but is unlikely to be commer-
cially feasible in the Americas. Likewise,
rodent control may also be impractical given
the wide geographic range of hantavirus
infection among feral rodent species (70).
Studies are ongoing to determine whether a
vaccine for wildlife, analogous to the one suc-
cessfully developed and used against rabies,
will be practical (71). 
Leptospirosis. Leptospirosis is an acute
febrile infection caused by bacterial species of
Leptospira that affect the liver and kidneys. It
is probably the most widespread zoonotic
(animal-to-human transmission) disease in
the world, and it is particularly common in
the tropics. Infection is caused by exposure
to water, damp soil, or vegetation contami-
nated with the urine of infected wild and
domestic animals (e.g., dogs and rodents)
(72). Outbreaks often occur after heavy rain-
fall during floods. The disease is strongly
associated with rice and sugarcane farming,
mining, and work with sewage and slaugh-
terhouses. Leptospirosis also has been linked
to outdoor recreation such as white water
rafting and camping. 
Although only 50–150 leptospirosis cases
are reported annually in the United States,
the disease is underdiagnosed (73). A study
found leptospira in 90% of rats sampled in
Detroit, Michigan, and a signiﬁcantly higher
exposure to the organism was found in inner-
city children (over 30%) versus suburban
children (73). In inner-city Baltimore, lep-
tospiral antibody prevalence was 16% and
associated positively with age, sex, race, and
bird ownership (74).
Finally, antibody to hepatitis E is wide-
spread in rats in the United States (75). This
serious viral illness has been linked to mater-
nal mortality in the developing world. High
prevalence levels now found in rats in the
United States increase the likelihood that
human infection may be possible in industri-
alized countries, though the role in human
epidemiology remains to be deﬁned.
Role of Climate
The ecology, development, behavior, and
survival of arthropod vectors and hosts and
the transmission dynamics of the diseases
they transmit are strongly influenced by cli-
matic factors. Temperature (in all seasons),
rainfall, and humidity are especially impor-
tant, but other factors such as wind and the
duration of daylight can also be signiﬁcant. In
particular, daily maximum and minimum
temperatures affect the pathogen’s rate of
multiplication within the insect, which in turn
affects the rate of salivary gland infection and
hence the likelihood of successful transmission
to another host. If the development time of
the pathogen exceeds the life span of the
insect, transmission cannot occur; vector
longevity is thus very important and can be
shortened by elevated temperatures. It is the
complex interplay of all these factors that
determines the overall effect of climate on the
presence or absence and local prevalence of
arthropod-borne diseases. Human activities
and behavior are also crucial to determining
whether transmission to humans will occur.
The location of homes in relation to the
breeding sites, the structure of buildings, the
materials used to build them, and the daily
patterns of human behavior—social life, work,
rest, and recreation—can all be important.
Mosquito-Borne Diseases 
In the United States, changes in lifestyles and
living conditions were major factors in the
disappearance of malaria, dengue, and other
mosquito-borne diseases. Unless living stan-
dards deteriorate drastically, such factors will
remain dominant. In many regions, summer
temperatures are higher than in much of the
tropics where the diseases remain common. If
the present warming trend continues, strate-
gies to avoid these temperatures—particularly
indoor living and air conditioning—are likely
to become more prevalent. Consequently, the
proneness to epidemics, already very low, will
continue to decline (9,20,42,50,76).
This does not mean that disease will be
entirely absent, and some diseases are reappear-
ing in urban areas. International travel and
population movement will facilitate introduc-
tions from other parts of the world. For exam-
ple, in 1997 the World Health Organization
recorded 12,328 cases of imported malaria in
the European region. Such cases occasionally
lead to summertime transmission, recently
reported as far north as Toronto, Canada, and
Berlin, Germany. However, in all developed
countries, such outbreaks are likely to be small,
easily contained, and confined to a limited
geographic area.
Climate-related natural disasters may
change the dynamics of human–mosquito
contact; floods may create conditions that
allow mosquito proliferation and enhance
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mosquito–human contact (e.g., residents in a
disaster area and recovery workers working
outdoors or living in substandard storm-dam-
aged housing) (77). Although encephalitis
epidemics do not consistently follow hurri-
cane- or ﬂood-related disasters in the United
States, arbovirus activity has been detected in
mosquitoes and host animals after numerous
disasters (77,78) (Table 1).
Dengue fever and climate sensitivity. In
the laboratory the rate of dengue virus repli-
cation in Ae. aegypti mosquitoes increases
directly with temperature (79). Models have
been developed to explore the influence of
projected temperature change on the inci-
dence of dengue fever (80). General circula-
tion models (GCMs) of climate change
scenarios on a global scale were linked to a
simulation model of dengue fever. These
models suggest that relatively small increases
in temperature in temperate regions, given
viral introduction into a susceptible human
population, should increase the potential for
epidemics (81,82). However, epidemic
potential depends on the interaction of many
virus, host, and environmental parameters,
and the models cannot accurately predict
actual risk of human cases without incorpo-
rating site-speciﬁc human, viral, and environ-
mental determinants of transmission. For
example, the summer mean temperature in
the Southeastern United States is actually
2–3°C higher than in Caribbean islands. Yet
the latter experience major epidemics of
dengue fever, whereas the United States does
not, despite the fact that the mosquito vectors
are present and there has been increased
imported dengue in the past 20 years.
Encephalitis and climate sensitivity.
Epidemics of SLE generally occur south of
the 20°C June isotherm (83), but northerly
outbreaks have occurred during unseasonably
warm years (30). Outbreaks of SLE are asso-
ciated with several-day periods when temper-
atures exceed 85°F (30°C) (84), as was the
case during the 1984 California epidemic
(85). Precipitation patterns also affect trans-
mission (17). In the West, increased snow-
pack and river runoff increase Culex tarsalis
abundance (78); in the Midwest, epidemics
have been associated with decreased rainfall
that allows Culex pipiens species to increase in
urban drainage systems (86); in Florida,
increases in transmission have been associated
with epic rainfall events that trigger oviposi-
tion and blood feeding by Culex nigripalpus
(87); and in the Eastern United States, out-
breaks of SLE appear to be associated with
the sequence of warm, wet winters, cold
springs, and hot dry summers. The factors
underlying this association remain a matter
for speculation (78,88). 
Field studies in California suggested that
a 3–5°C increase in average temperature may
cause a northern shift in the distribution of
both WEE and SLE viruses and a decreased
range of WEE in southern California
(89,90). Viral development time in the mos-
quito at higher temperatures is detrimental
to WEE virus and is an important factor dri-
ving these results (Figure 2) (89,90). In the
Eastern United States, wind can play a role
in dispersing mosquitoes potentially infected
with EEE as far north as upstate New York
and Michigan (91) (Table 1). 
Malaria and climate sensitivity. The
temperature threshold for the development of
P. falciparum and P. vivax in their anopheline
hosts is 18°C and 15°C, respectively. The
incidence and prevalence of malaria may be
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Table 1. Some effects of weather and climate on vector- and rodent-borne diseases.a
Vector-borne pathogens spend part of their life cycle in cold-blooded arthropods that are subject to many environ-
mental factors. Changes in weather and climate that can affect transmission of vector-borne diseases include tem-
perature, rainfall, wind, extreme flooding or drought, and sea-level rise. Rodent-borne pathogens can be affected
indirectly by ecologic determinants of food sources affecting rodent population size, and ﬂoods can displace and lead
them to seek food and refuge.
Temperature effects on selected vectors and vector-borne pathogens
Vector
Survival can decrease or increase depending on the species (88,90)
Some vectors have higher survival at higher latitudes and altitudes with higher temperatures
Changes in the susceptibility of vectors to some pathogens—e.g., higher temperatures reduce the size of some 
vectors (129–131) but reduce the activity of others (9,132)
Changes in the rate of vector population growth (133)
Changes in feeding rate and host contact (which may alter the survival rate) (131,134)
Changes in the seasonality of populations (135)
Pathogen
Decreased extrinsic incubation period of pathogen in vector at higher temperatures (79,136,137)
Changes in the transmission season (89,131)
Changes in distribution (83)
Decreased viral replication (90)
Effects of changes in precipitation on selected vector-borne pathogens
Vector 
Increased rain may increase larval habitat and vector population size by creating a new habitat
Excess rain or snowpack can eliminate habitat by ﬂooding, thus decreasing the vector population size
Low rainfall can create habitat by causing rivers to dry into pools (dry season malaria)
Decreased rain can increase container-breeding mosquitoes by forcing increased water storage (80)
Epic rainfall events can synchronize vector host-seeking and virus transmission (87)
Increased humidity increases vector survival (138); decreased humidity decreases vector survival
Pathogen 
Few direct effects but some data on humidity effects on malarial parasite development in the anopheline 
mosquito host.
Vertebrate host
Increased rain can increase vegetation, food availability, and population size
Increased rain can also cause ﬂooding and decrease population size but increase contact with humans
Decreased rain can eliminate food and force rodents into housing areas, increasing human contact, but it can 
also decrease population size
Increased sea level effects on selected vector-borne pathogens
Alter estuary ﬂow and change existing salt marshes and associated mosquito species, decreasing or eliminating 
selected mosquito breeding sites (e.g., reduced habitat for Culiseta melanura)
aThe relationship between ambient weather conditions and vector ecology is complicated by the natural tendency for insect vectors to
seek out the most suitable “microclimates” for their survival (e.g., resting under vegetation or pit latrines during dry or hot conditions
or in culverts during cold conditions).
Figure 2. WEE and SLE viral development and temperature. Data from Reeves et al. (90). 
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limited by altitude (92), a good proxy for
temperature, but malaria transmission
depends on many factors besides temperature.
Although malaria tends to be seasonal, there
is substantial interannual heterogeneity of
malarial incidence around the globe (93,94).
Extremes of rainfall (both drought and
floods) associated with El Niño events are
linked to variability in malarial incidence in
different regions (95,96). 
Some biologic modeling of the potential
impact of climate variables, primarily temper-
ature increases, on malaria as done on a
global scale projected net increases in the geo-
graphic area and season for potential malaria
transmission (97,98). However, a statistical–
empirical model approach that used the base-
line number of people currently living in
malaria-endemic regions (99) found no sig-
nificant net change in malaria projected by
the year 2080. It is possible that small
increases in minimum temperature in cooler
regions may disproportionately increase
malaria transmission (100,101), provided
there are no socioeconomic barriers to trans-
mission as there are in the United States. It is
difficult to extrapolate the data from these
global malaria/climate models (100) from the
situation in Africa (102,103) or from El
Niño/malaria studies conducted in South
America (96) to the United States.
In temperate countries, people rarely are
bitten by anopheline mosquitoes unless they
live near mosquito-breeding sites. Even then,
window screens or human behavior of staying
indoors in closed, air-conditioned houses in
the evening limits human–mosquito contact.
This is underscored by the fact that even
though the United States has experienced
increased frequency of local transmission as
the result of increased imported disease in the
past decade, all of the incidents have resulted
in only 1–3 cases and have involved migrant
workers or immigrant populations living in
substandard housing (50,104). Other nonen-
demic countries have also reported malaria
recently. After 40 years of being malaria free,
transmission of P. vivax malaria by local vec-
tors has been reported in Italy (105,106). In
France, about 5,000 imported cases are
reported per year, but local transmission has
rarely been reported. However, a major resur-
gence of epidemic malaria has occurred in the
southern republics of the former Soviet
Union because of the breakdown of public
health services (107).
Various factors would either promote or
deter the recurrence of autochthonous
malaria in the United States if climate condi-
tions continue to warm. For example,
increased travel and commerce have brought
and will continue to bring infected travelers
and/or vectors to the United States. Also,
drug resistance may lessen our ability to treat
malarial infections. On the other hand,
factors that make sustained endemic or epi-
demic transmission unlikely include current
land use and agricultural practices, improved
housing, improved mosquito control, and
human behavioral avoidance of mosquitoes
(e.g., time spent indoors with screened win-
dows and air conditioning) and led to the
elimination of malaria in the United States
historically; these conditions are unlikely to
change with global warming. Moreover, most
areas have good medical services, and there is
effective treatment for malaria (with the
caveat that vigilance for drug resistance will
always be of concern).
Tick-Borne Diseases
Ticks and their mammalian hosts are
inﬂuenced by land use, land cover, soil type,
elevation, and weather conditions (108–111).
One disease, RMSF, has been modeled
under climate-change scenarios (112), which
show summertime temperatures in the
Southeast becoming too hot for tick survival
and the consequent reduction in the risk of
RMSF (Table 1). However, tick-borne/cli-
mate–related models have limitations. For
example, the effect of climate change on the
presence of nonmammalian hosts, such as
lizards, that may act as a zooprophylaxis
requires further study. 
Rodent-Borne Diseases
The potential effects of climate variability and
change on infectious agents transmitted by
mammals to humans are more uncertain and
have received less attention than have vector-
borne diseases. Because El Niño events may
lead to increased rainfall in certain regions of
the United States, studying such events may
allow a better understanding of the potential
implications of one climate-change scenario
on rodent population fluctuations and pat-
terns of diseases, such as hantavirus and
plague. On the other hand, consistent
increased rainfall will likely change the ecol-
ogy of these regions and thus the ecology of
the disease.
Hantavirus and climate sensitivity.
Ecologic changes promoting rapid increases
and then decreases in rodent populations
have a marked association with size of han-
tavirus disease outbreaks (67). The changes
that affect rodent population dynamics are
often weather related and include the combi-
nation of unusually high rainfall followed by
drought. For example, the U.S. Four Corners
outbreak in 1993 was preceded by a dramatic
increase in rainfall associated with the
1992–1993 El Niño. This led to increased
rodent food resources, a focal 20-fold increase
in the rodent population, and an increased
risk of human disease (113,114). By 1995,
both the rodent population and human cases
had decreased dramatically (113). A similar
pattern of above-average rainfall followed by
drought was observed preceding an outbreak
of hantavirus pulmonary syndrome in
Paraguay during 1995–1996 (115). 
Since the 1993 hantavirus pulmonary syn-
drome outbreak, longitudinal studies have
monitored animal reservoir populations in the
Southwestern United States (66,69). Models
combining satellite images of weather condi-
tions and human disease surveillance also were
developed to allow regions at increased risk to
be identified with sufficient lead time for
public health intervention (114). 
Leptospirosis and climate sensitivity.
Extreme flooding or hurricanes can lead to
outbreaks of leptospirosis. The October 1995
epidemic of leptospirosis in Nicaragua fol-
lowed heavy flooding (116). A case–control
study showed that a 15-fold risk of disease was
associated with walking through flooded
waters (117). High-risk factors also included
having rodents or dogs in the household. A
large epidemic of leptospirosis overlapped with
an outbreak of dengue in 1996 in Salvador,
Brazil (118). The peak of the epidemic
occurred 2 weeks after severe ﬂooding in the
area. Poor living conditions were associated
with increased risk. Forty-three percent of the
patients were misdiagnosed as having dengue
fever and hence not treated with antibiotics. 
Plague and climate sensitivity. Some
studies have found that ambient temperature,
rainfall, and relative humidity, along with
rodent habitat, affected the seasonal abun-
dance of rodent fleas in the western United
States (119–121). Climatic events such as
periods of increased precipitation or drought
also strongly affect rodent population dynam-
ics, largely through effects on food availability
(122–125). Flea-borne plague incidence has
been found to rise in conjunction with
increasing rodent populations following
unseasonal winter/spring precipitation in
New Mexico (126). Responses of both fleas
and rodents to climatic factors vary consider-
ably from species to species. The association
of climate and habitat on the incidence of
human plague somewhat resembles that pos-
tulated for the effects of these factors on the
occurrence of human hantavirus cases. 
Table 2 lists ﬁeld and modeling studies on
vector-borne diseases and climate variability
and change. The current infectious disease
models do not do well at predicting future
incidence of disease because they lack an ade-
quate characterization of the feedback effects
between weather-related changes in the ecol-
ogy and the spread of infected vectors and
disease. Yet even though no model can accu-
rately simulate real life, models are useful in
conceptualizing dynamic processes and their
outcomes. Multiple iterations of well-
conceptualized models help identify key
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knowledge gaps and guide empirical studies
that ultimately will lead to improved models.
At present, long-term regional weather and
ecologic predictions still remain major barri-
ers to predicting future changes in vector-
borne disease risks.
Adaptive Capacity
Understanding the vulnerability of the
United States to changes in the ranges or rates
of vector-borne diseases is the first step in
addressing adaptive capacity. Adaptation
involves the ability to change behavior or
health infrastructure to reduce the potential
negative impacts of climate change.
Adaptation is a function of a number of soci-
etal systems, including access to financial
resources (both for individuals and popula-
tions), technical knowledge, public health
infrastructure, and capacity of the health care
system. Adaptation can be viewed as taking
place on two levels: autonomous adaptation,
which is the natural or spontaneous response
to climate change by affected individuals; and
purposeful adaptation, which is a planned
response to climate change, typically by gov-
ernmental or other institutional organiza-
tions. Anticipatory adaptations are planned
responses that take place in advance of cli-
mate change. It is important to identify and
prioritize anticipatory adaptations to prevent
irreversible adverse impacts that can not be
mitigated after they occur. Some examples of
adaptive options are: 
Environmental controls
• Mosquito control programs (e.g., with
pesticides or predator ﬁsh species)
• Community elimination of aquatic breed-
ing sites
• Window screens, air conditioning, and
other personal protective measures.
Technologic or administrative controls
• Vaccine, pharmaceutical, and pesticide
development
• Improved and expanded surveillance
efforts 
• Education initiatives for health care givers
• Behavioral controls
• Proper clothing and use of repellents
• Following of instructions for prophylactic
measures when traveling abroad.
Little quantitative information is available
on adaptation to climate change. Insights on
potential vulnerabilities and recommendations
for policies to promote adaptation can be
gained from past experiences in public health.
For example, many formerly endemic mos-
quito-borne diseases such as malaria, dengue
fever, and yellow fever are rare or have disap-
peared, primarily because of changes in living
conditions (such as adequate housing, the use
of screens on doors and windows, and the use
of air conditioning), changes in behaviors
(such as watching television instead of sitting
outside during biting times), and public
health interventions (such as vector control
programs). Although changes in the range of
both Ae. aegypti and Ae. albopictus could
occur with changing climate, the above
factors plus the current public health infra-
structure, including active disease surveil-
lance and selected vector control, reduce the
risk of the increased transmission potential of
the disease agents that can be carried by these
mosquitoes. Maintaining this infrastructure
is important to ensure that the risk does not
change with changing climate. Prioritizing
disease risks will differ across the country
because of geographic and climatologic
variability; therefore, adaptive responses
must be tailored to region.
The capacity to adapt to potential changes
in climate will depend on many factors,
including at least maintaining the current
level of public health infrastructure; ensuring
active surveillance for diseases with poten-
tially large public health impacts; continuing
research to further our understanding of the
associations among weather, extreme events,
and vector-borne diseases; and continuing
research into medical advances required for
disease prevention, control, and treatment,
such as vaccines and methods to deal with
drug-resistant strains. For example, very high
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Table 2. Examples of ﬁeld or modeling studies of climate variability and change.
Study Findingsa
Encephalitis
Reeves and Hammon, 1962 (78) One hundred human cases of WEE and 89 cases of SLE occurred in Kern County, 
California, following the Tehachapi earthquake and ﬂood of the Kern River 
in 1952.
Nasci and Moore, 1998 (77) Fifty-ﬁve human cases of WEE and 12 of SLE occurred in Minnesota after 
the Red River ﬂood of 1975.
Reisen et al., 1993 (89) 1°C increase in temperature corresponds with a 1% decrease in adult Culex 
Reeves et al., 1994 (90) tarsalis mosquito daily survivorship but shortened viral development time in 
the mosquito. Conclusion: A 3–5°C increase in average temperature may 
eliminate WEE from the United States and cause a northern shift in the 
distribution of both WEE and SLE outbreaks in California. 
Sellers and Maarouf, 1990 (91)b Analyses of wind trajectories indicated that mosquitoes potentially infected 
with EEE virus could be carried by storm fronts from North Carolina northeast-
ward as far as upstate New York and from western Kentucky to Michigan.
Dengue
Jetten and Focks, 1997 (81)b In the dengue fever simulation model (DENSiM), Jetten and Focks projected 
Patz et al., 1998 (82)b that increasing temperature would increase the length of transmission season 
in temperate regions. Patz et al. applied DENSiM to future climate scenarios 
generated from general circulation models (GCMs). These models projecting 
potential epidemic transmission are sensitivity analyses only; human cases 
can not be determined since the models used in these studies are not fully 
parameterized and therefore cannot be used for regional predictions.
Malaria
Haile, 1989 (112)b Except for Rogers and Randolph, who used statistical modeling, these
Martin and Lefebvre, 1995 (139)b studies used biologic process models and GCMs of future climate change
Martens et al., 1995 (97)b scenarios. Haile (in 1989) found little change in malarial transmission risk in 
Rogers and Randolph, 2000 (99) the United States. As with the dengue simulations, this and the other studies 
Martens et al., 1999 (98) projecting potential epidemic malaria transmission are only sensitivity 
Lindsay and Martens, 1998 (103) analyses; because these models are not fully parameterized, they cannot be 
used for regional prediction.
Bouma et al., 1997 (96) El Niño events were linked to variability in malarial incidence in Colombia and
Venezuela, South America.
Tick-borne disease
Haile, 1989 (112)b Future warming from double carbon dioxide in the Southeast may reduce tick 
survival and subsequent risk of Rocky Mountain spotted fever. 
Amerasinghe et al., 1993 (108) There was a signiﬁcant correlation between Lyme disease tick density and 
rainfall and elevation.
Mount et al., 1993 (109) Tick abundance was predicted by land use, land cover (especially forest edge), 
Glass et al., 1994 (110) soil type, elevation, and the timing, duration, and rate of change in 
Wilson, 1998 (111) temperature and moisture.
Rodent-borne disease
Trevejo et al., 1998 (117) A 15-fold increased risk of leptospirosis was associated with walking through 
ﬂooded waters (Nicaragua).
Ko et al., 1999 (118) An urban oubreak of leptospirosis in Salvador, Brazil, peaked 2 weeks after 
severe ﬂooding.
Engelthaler, 1999 (113) The Four Corners hantavirus outbreak in 1993 was preceded by a dramatic 
increase in rainfall from the 1992–1993 El Niño, with a 20-fold explosion in 
the rodent population.
aWeather parameter italicized. bMaintenance and transmission of these disease agents in nature depend on many complex ecologic
interactions among the vector, the pathogen, the vertebrate host, and the environment. Therefore, these models should be considered
only sensitivity analyses, not predictive models.
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priority should be given to development of
more effective mosquito control and vaccines
for the two major vector-borne diseases,
malaria and dengue. Both are maintained pri-
marily in a mosquito–human–mosquito
transmission cycle and could be prevented
effectively by immunizing humans. Although
progress on vaccines for both diseases has
been promising in recent years, it will likely
be another decade before safe and effective
vaccines are available for public health use.
Therefore, funding for vaccines should not
occur at the expense of research needed to
understand environmental determinants of
disease transmission and mosquito control
methodologies. In addition, research is
needed to identify adaptation needs, to evalu-
ate adaptation measures, and to set priorities.
The goal is to prevent, rather than treat,
disease to reduce human suffering. 
CDC Arbovirus Surveillance and
Response Activities
Surveillance. Arbovirus transmission within
the United States is monitored by state and
local health departments and the CDC
Division of Vector-Borne Infectious
Diseases (CDC-DVBID). The CDC obtains
information through well-organized, system-
atic processes [e.g., National Electronic
Telecommunications System Surveillance
(NETSS)] and through a loosely organized
network of workers in both state and local
health departments and municipal mosquito
and vector control agencies. Incoming infor-
mation is received via phone, fax, mail, and
an e-mail listserver (VECTOR) maintained
by DVBID.
Human arbovirus cases are required to be
reported by the state health departments and
are monitored through NETSS, as are other
reportable diseases in the country. Summaries
of arbovirus cases are routinely disseminated
to all 50 state health departments and certain
key counties and diagnostic laboratories
through the VECTOR listserver.
The arboviral equine encephalitides also
cause veterinary disease, and cases may be
reported to health or agriculture departments
in the states. Certain health departments and
veterinary diagnostic laboratories, including
the U.S. Department of Agriculture-National
Veterinary Services Laboratory, provide infor-
mation regarding veterinary cases to CDC-
DVBID. This information is summarized
and disseminated via the VECTOR listserver.
Nationwide, routine entomologic and
environmental surveillance for arbovirus
transmission activity is conducted by certain
states that maintain intensive, statewide sur-
veillance programs to monitor enzootic and
epizootic arbovirus transmission activities. A
few large counties and municipal mosquito
control districts also conduct surveillance
programs. CDC-DVBID supports these
surveillance programs. 
Response. Information is regularly evalu-
ated on environmental surveillance and
human and veterinary cases, and summaries
are provided to health department workers via
the VECTOR listserver. If trends suggest
increases in transmission activity or abnor-
mally early or late transmission activity, CDC-
DVBID alerts the state health department(s)
involved and offers diagnostic laboratory sup-
port and on-site epidemiologic assistance by
DVBID staff in evaluating the epidemic,
enhancing surveillance activities, and coordi-
nating emergency vector control activities.
Gaps in surveillance and response capa-
bilities. Gaps in surveillance and response
capabilities are related primarily to the lack of
surveillance infrastructure and lapses in com-
munication systems. First, human case sur-
veillance via NETSS is slow. The time lag
between the diagnosis and conﬁrmation of an
arbovirus case and its appearance in NETSS
is often quite long. Moreover, results of
human diagnostic tests done in commercial
laboratories may not be communicated to the
state health department.
Veterinary case surveillance and reporting
of cases must be integrated better with public
health activities. Veterinarians sometimes do
not obtain samples or request appropriate
diagnostic testing. Results of samples that are
tested often are not communicated to state or
county health departments for timely evalua-
tive follow-up, and few states require report-
ing of veterinary arbovirus cases. Better
communication among human public health
agencies, veterinary services, and organizations
is essential.
Environmental and entomologic surveil-
lance programs monitoring arbovirus trans-
mission activity in vectors and vertebrate
hosts are highly variable. Some states (e.g.,
California, Florida, New Jersey) maintain
well-designed, comprehensive surveillance
programs that monitor enzootic and epizootic
transmission activity, veterinary cases, and
human cases. Within several states, large
counties (e.g., Harris County, Texas) also
maintain intensive environmental surveillance
programs. Other states and counties maintain
only marginally effective or no environmental
or veterinary surveillance programs. Support
for arbovirus surveillance programs is fre-
quently a very low priority in state health
departments, and interest and capability
regarding arboviruses have lessened over the
past 20–30 years. Finally, surveillance and
reporting technique differences make evalua-
tion of data difﬁcult. 
In summary, there is no systematic method
of assembling a national database of environ-
mental or veterinary surveillance data, and
most data are provided to CDC voluntarily.
Guidelines for arbovirus surveillance have been
published (128), but the infrastructure
required to implement effective surveillance
and prevention programs is not available.
Research Needs and Data Gaps
Weather and climate are important parame-
ters in the epidemiology of vector-borne dis-
eases. The effects of such variables as
temperature and rainfall are very complex,
inﬂuencing the vector and its interaction with
both habitat and vertebrate hosts, all of which
determine whether a disease pathogen will be
present and, if so, whether transmission will
be endemic or epidemic (Figure 3). Without
well-designed research to understand these
interactions, accurate projections of the
potential effects of climate change on disease
will remain elusive.
Climate change is likely to affect the
transmission patterns of vector-borne
pathogens, but more research is needed to
clarify the interactions of weather variables
and the diseases they affect. There is a need
for information on how zoonoses persist in
nature and what triggers their amplification
and initiation of secondary cycles that
increase the risk of human infection. Some
diseases may increase but others may
decrease. How these pathogens persist and
what triggers amplification must be under-
stood before the role of weather and long-
term climate trends can be fully determined. 
There has been an increase in the num-
ber of imported cases of dengue and malaria
in the United States since the 1980s, as well
as increased local transmission (1,50). The
differential dengue incidence rates at the
U.S.–Mexico border illustrate deﬁciencies in
knowledge regarding the specific socio-
economic determinants of disease and its
prevention.
Figure 3. Framework for assessing potential impacts of
climate change on vector-borne diseases. Arrows 1, 2,
and 3 indicate direct climate change effects. Data from
Chan et al. (4). 
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Malaria research is one example of our
lack of understanding of the potential impli-
cations of climate change for the United
States. It has been demonstrated for 50 years
that when malaria is reintroduced into this
country, the sociologic and ecologic condi-
tions limit human–mosquito contact, and the
public health system has been able to suppress
disease outbreaks quickly. There have been
no rigorous assessments of the behavior and
vector competence of U.S. Anopheles since the
1950s. Public health focus has been on case
detection and treatment, but attention should
include monitoring of the indigenous
Anopheles mosquitoes.
There is a need for well-designed, multi-
disciplinary ﬁeld research on diseases in their
natural habitats to discern better the effect of
weather on the natural maintenance cycles,
disease incidence, and epidemic potential.
Contemporary process-based mathematical
models can be useful tools to explore the
interaction of variables in the transmission
dynamics of a disease. See Table 3 for further
recommendations for surveillance and model-
ing needs. Certainly as a foundation for such
modeling, improved epidemiologic surveil-
lance at all levels of the health system is
important.
Only limited databases are available to
address the health impacts of extreme climate
variability and change. Much of the informa-
tion comes from epidemic investigations in
which researchers focus on a single event and
gather data for only a short time. A concerted
effort to acquire more complete, long-term
data sets is essential. Resolving the many
questions about associations among weather,
climate, and disease will require the identiﬁ-
cation of model systems or diseases, which
would enable the development of long-term,
high-quality data sets, and sustained funding
to make this research possible.
Although it is likely that warming trends
and other changes projected by global cir-
culation models could affect vector- and
rodent-borne diseases in the United States,
the details and degree of these effects are
uncertain. In addition, we do not know how
projected climate change will affect the com-
plex ecosystems required to maintain dis-
ease. Understanding these issues will require
considerable research on the influence of
weather and climate on these pathogens in
their natural transmission cycles. In the
future, assessments that integrate global cli-
mate scenario-based analyses with local
demographic and environmental factors are
needed to guide comprehensive, long-term
preventive health measures. 
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Table 3. Proposed research agenda for climate change and infectious disease.a
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for projecting the climate variables most useful to research on the health impacts of climate change.
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pathogens and vectors.
Disease surveillance 
Improve morbidity and mortality surveillance for selected diseases, including active surveillance with laboratory 
conﬁrmation in areas of special interest.
Improve methods of detecting pathogens in vectors and in the environment.
Technologies for disease prevention and mitigation: Assess existing technologies and develop new ones, such as
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Rapid methods for ﬁeld diagnosis of disease
Genetic techniques for identifying vectors and pathogens
Disease transmission dynamics 
Elucidate the biologic, biophysical, and biochemical interactions among pathogens, vectors, and hosts that
inﬂuence disease transmission.
Develop disease transmission models that accurately incorporate these complex interactions.
Data sets for empirical studies 
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information systems.
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